BrainJuicer Group plc beats forecasts, but is it a better buy than Next Fifteen Communications plc?

Both these marketing firms could grow alongside quality client lists including Heineken, Shell, Apple and Microsoft. But which, if any, should you buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This morning BrainJuicer plc (LSE: BJU), the unorthodox marketing firm, upgraded full-year profit forecasts on the back of strong performances from its Advertising Testing and Brand Tracking services. The company boasts an impressive client portfolio, including Heineken, Hershey’s and Shell.

Another extraordinary marketing firm, Next Fifteen Communications (LSE: NFC), has an equally impressive customer base including Alphabet, Apple and Microsoft.

Many investors believe these two companies could grow alongside their clients, but is BrainJuicer the better buy after today’s positive update, or does Next Fifteen’s consistent track record give it the edge?

BrainJuicer doesn’t believe in persuading customers using facts and figures. Humans tend to make snap decisions and consider only the top three or four brands when buying low-ticket items like ice creams.

Therefore, rather than focusing on the logical qualities of a product BrainJuicer bases its campaigns around “Fame, Feeling and Fluency.”

This novel approach drove an incredible 30% compound annual revenue growth rate between 2005 and 2013, with profits following along. The company’s expansion has been more muted in recent years however, growing only 3% total since then.

Its share price is approaching all-time highs, which seems overdone considering recent lacklustre revenue growth. Management also failed to quantify the outperformance, therefore lowering its value.

Today’s news is great for current shareholders, but a PE of 20 times might seem a little steep for those looking to buy the shares, especially if BrainJuicer can’t reignite revenue growth.

Two decades of growth

Next Fifteen Communications provides tech giants with PR, marketing and niche technical services.

The company might not have expanded as quickly as BrainJuicer, but its track record is no less impressive given its consistency. It has been profitable in all but two of the last 20 years and has grown revenue from £7.9m to £129.8m, or a CAGR of 6.9% in the same period.

A slew of acquisitions has turned it into a full-service provider over the last few years, which could facilitate revenue growth for some time.

BrainJuicer’s revenue growth has slowed down a little over the last few years, but Next Fifteen’s has been picking up the pace, jumping 23% last year.

I believe Next Fifteen’s revenues could be more defensible than BrainJuicer’s too because serving companies like Apple requires a deep understanding of tech that isn’t easily replicated.

BrainJuicer or Next15?

BrainJuicer has used its pause in growth to focus on margin expansion. The company reported an impressive 19% operating margin last year, compared to Next Fifteen’s 8%. Such a high figure implies that its services are still unique, otherwise competition would likely drag down profitability towards single-digits.

Next Fifteen trades at a rich 60 times last year’s earnings, but this figure doesn’t take into account the company’s rapid expansion, or its strong cash-flow. You see, earnings have recently been hit by high amortisation costs following past acquisitions. If we ignore these non-cash charges, the company looks a little cheaper at only 23 times free cash flow generated in the last 12 months.

Interestingly, BrainJuicer trades on 22 times the same metric. 

Both these companies are worth a closer look, in my view, but I believe Next Fifteen’s recent momentum make it a more attractive proposition than BrainJuicer’s, in spite of today’s upgrade.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zach Coffell has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »